Quantcast

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

October 29, 2013

Reportbuyer.com just published a new market research report: Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017.

London (PRWEB) October 29, 2013

Rising incidence of diabetes, heart conditions and cancer are underpinning the physician-based POC diagnostic sector’s rapid growth.

The market for POC diagnostic products used in the physician’s surgery was worth approximately US$4.1 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term with the market forging ahead to be valued at over US$6 billion by 2017.

In the physician's office, POC diagnostics can play a key role in the diagnosis and ongoing monitoring of acute and chronic illnesses, the detection of some types of cancer, the monitoring of patients on anticoagulation drugs, and for general blood and urine testing. It can also play an important role in enabling preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and identifying patients with risk factors that mean they are likely to develop such conditions in the future.

There are several key challenges in the market. Currently, many physicians’ offices do not have budgets for in-house diagnostic testing and healthcare funding needs to change in order to provide incentives for doctors to use the products. For this to happen, healthcare providers need evidence that POC diagnostics provide benefits in terms of clinical-usefulness, convenience and cost.

This volume provides…

Market growth forecasts by sector to 2017

Over 100 companies listed with 14 detailed profiles

Detailed operating environment analysis

All major testing technologies are covered

Haemoglobin (HbA1c)

Cholesterol

Coagulation

Tumour marking

C-reactive protein (CRP)

Urinalysis

Haematology & clinical chemistry

About the Author

This report has been researched and written by independent medical market analyst Joanne Maddox. For over 13 years she has played a pivotal role in tracking trends in medical device and equipment markets and companies. A former editor of Medical Device Companies Analysis she has also written The Global Advanced Wound Care Market to 2017; Advances in Molecular Imaging 2013; and, Telemonitoring: Challenges and Opportunities.

About the Publisher

For over 30 years Espicom Business Intelligence, a Business Monitor company, has been a leading provider of key medical device and technology data. Its experienced and knowledgeable authors are uniquely placed to produce this high-quality and thoroughly researched management report. Espicom is part of Business Monitor International.

Table of Contents

MARKET OVERVIEW 1

EXECUTIVE SUMMARY 1

INTRODUCTION 2

Physician’s Office POC Testing 2

The Role of POC Testing in a Physician’s Office 3

Regulatory and Reimbursement Environment 4

CLIA Waiver 4

CURRENT MARKET DYNAMICS 6

Fig 1: POC Diagnostics in Relation to the IVD Market, 2011 6

Fig 2: Percentage of POC Diagnostics Market by Product, 2011 7

Regional Perspective 7

Fig 3: Professional POC Diagnostics Market by Region, 2011 8

Physician’s Office POC Testing Market 8

Addressable Markets for Physician’s Office POC Testing, 2007-2011 (US$ million) 10

Fig 4: Addressable Markets for Physician’s Office POC Testing, 2011 10

Fig 5: Physician’s Office POC Testing Market, 2011 11

GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES 12

POC Diagnostics and the Economy 12

The Burden of Chronic Disease and Preventative Medicine 12

Clinical Utility and Accuracy 14

POC Diagnostics as a Disruptive Technology 14

Emerging Technologies 15

Summary: Market Drivers, Restraints and Opportunities 16

COMPETITIVE LANDSCAPE 17

Market Leaders for Physician’s Office POC Testing Products 17

Select POC Diagnostics Companies’ Sales, 2007-2011 (US$ million) 17

Merger and Acquisition Activity 17

Key POC Diagnostics Mergers and Acquisitions, 2008-2011 18

FUTURE MARKET PROSPECTS 20

Addressable Markets for Physician’s Office POC Testing, 2011-2017E (US$ million) 21

Growth in the Addressable Markets for Physician’s Office POC Testing, 2008-2017E (%) 21

Physician’s Office POC Testing Market, 2011-2012E (US$ million) 21

Fig 6: Physician’s Office POC Testing Market, 2012(E) 22

PHYSICIAN’S OFFICE POC PRODUCTS AND TECHNOLOGIES 23

POC HBA1C TESTING 23

Diabetes Prevalence and Burden to the Healthcare System 23

Fig 7: Diabetes Prevalence by Geographic Region, 2011-2030 23

Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million) 24

Diabetes Management and the Role of HbA1c Testing 25

POC HbA1c Testing Market 27

Fig 8: Global POC HbA1c Testing Market, 2007-2017E (US$ million) 27

POC HbA1c Products 27

ApexBio’s A1C Express 27

Alere/Axis-Shield’s Afinion HbA1c and NycoCard HbA1c Tests 27

Bayer’s A1CNow Products 28

Bio-Rad’s in2it A1C Analyser 28

DiaSys Diagnostic Systems’ InnovaStar 28

Ceragem Medisys’ HbA1c Analysers 29

EKF Diagnostics’ Quo-Lab, Quo-Test and Biosen HbA1c Analysers 29

Infopia’s Easy/Clover A1c 29

Siemens’ DCA Vantage Analyser 29

Tosoh Bioscience’s G8 HPLC Analyzer 30

In Development 30

POC CHOLESTEROL TESTING 32

Cholesterol Testing and Preventative Medicine 32

POC Cholesterol Testing Market Dynamics 33

Fig 9: Global POC Cholesterol Testing Market, 2007-2017E (US$ million) 34

Fig:10: POC Cholesterol Testing Market by End User, 2011 34

Available Products 35

Alere’s Cholestech LDX System 35

Akers Biosciences’ Tri-Cholesterol Check 35

Chematics’ Chemcard Cholesterol Test 35

General Life Biotechnology’s BeneCheck LipidEx ST 35

Infopia’s Lipid Pro 36

Jant Pharmacal’s LipidPlus Lipid Profile and Glucose Test System 36

Miraculins’ PreVu Point of Care Skin Sterol Test 36

Distribution Agreements 37

Polymer Technology Systems’ CardioChek PA 37

Roche’s Accutrend Plus 38

Syntron Bioresearch’s Venture Total Cholesterol Test 38

Products in Development 38

Roche and Panasonic Healthcare 38

POC COAGULATION TESTING 39

POC Coagulation Testing Market Dynamics 39

Fig 11: Global POC Coagulation Market, 2007-2017E (US$ million) 40

The Impact of New-Generation Anticoagulants 40

Patient Self-Testing and Issues for Doctors 41

CoaguSense’s CoaguSense PT/INR Monitoring System 43

Alere’s INRatio2 System 43

International Technidyne Corporation’s ProTime Microcoagulation System 43

Roche’s CoaguChek XS 43

Professional Use Products 44

Alere’s Axis-Shield Products 44

Helena Laboratories’ Cascade POC System 44

Instrumentation Laboratory’s GEM PCL Plus 45

Roche’s CoaguChek Systems 45

CoaguChek XS Pro 45

CoaguChek XS Plus 45

CoaguChek XS 45

CoaguChek Link 45

Products in Development 46

Bio-AMD’s COAG 46

Siemens/Universal Biosensors’ POC Coagulation Tests 46

POC CLINICAL CHEMISTRY AND HAEMATOLOGY PRODUCTS 47

Multi-Functional POC Clinical Chemistry Analysers 47

Handheld POC Analysers Suitable for Use by Physicians 47

Abaxis’ Piccolo xpress 47

Abbott’s i-STAT System 48

Alere/Axis-Shield’s Afinion POC System 49

Alere/Axis-Shield’s NycoCard System 49

Benchtop Systems Suitable for Physician’s Laboratories 50

Alfa Wassermann’s ACE Clinical Chemistry Systems 50

Arkray’s SpotChem Systems 50

SpotChem Test Strips 51

Audit Diagnostics’ Liqui-Stat System 51

DiaSys Diagnostic Systems’ InnovaStar 51

Horiba’s ABX Pentra Clinical Chemistry Analysers 52

Ortho-Clinical Diagnostics’ VITROS DT60 II Chemistry System 52

Qualigen’s FastPack IP System 52

Samsung’s LABGEO Clinical Chemistry Analysers 52

Tosoh Bioscience’s AIA Immunoassay Analysers 52

POC Haematology and Haemoglobin Analysers 53

POC Haemoglobin Systems 53

POC Analyser Accuracy 53

ACON Laboratories’ Mission Hb Hemoglobin Testing Systems 54

ApexBio’s HemoSmart Haemoglobin Screening System 54

Audit Diagnostics’ Hb-Stat 54

Ceragem Medisys’ CERA-CHEK Hb Plus 54

EKF Diagnostics’ Products 54

General Life Biotechnology’s BeneCheck Hb Hemoglobin Test System 55

OrSense’s Glasswing and NBM 200 Systems 55

Quest Diagnostics’ HemoCue Haemoglobin Systems 56

URIT Medical’s URIT-12 Hemoglobin Meter 57

POC C-REACTIVE PROTEIN DIAGNOSTICS 58

Abaxis’ MetLyte Plus CRP and BioChemistry Panel Plus 58

Alere/Axis-Shield 59

bioMérieux bioNexia CRP Test 59

LifeAssays’ CRP 59

Medix Biochemica’s Actim CRP 59

Orion Diagnostica’s QuikRead and QuikRead go Systems 59

POC PHYSICIAN’S OFFICE INFECTIOUS DISEASE TESTS 60

Current Market Dynamics 61

Fig 12: Market for POC Infectious Disease Tests used in a Physician’s Office, 2007-2017E (US$ million) 61

POC Influenza Testing 61

Performance and Use of Rapid Influenza Tests in the US 62

CDC Recommendations 62

CDC: Influenza Prevalence and Test Accuracy 63

POC Influenza Testing Market 63

Future Prospects 64

CLIA-Waived Flu Detection Products 64

Alere’s Influenza Tests 64

Becton Dickinson’s BD Veritor System 64

Quidel’s Sofia Analyzer and Sofia Influenza A+B Fluorescent Immunoassays 65

Quidel’s QuickVue Influenza Tests 65

SA Scientific’s SAS FluAlert 65

Other POC Flu Detection Products 65

bioMérieux’ bioNexia Influenza A+B Tests 66

IQuum’s Liat Influenza A/B Assay and the Liat Analyzer 66

Jant Pharmacal’s Accutest Flu Test 67

Medix Biochemica’s Actim Influenza A&B 67

Meridian Bioscience’s TRU FLU 67

Mizuho Medy’s Quick Chaser Flu A,B 67

OraSure Technologies’ OraSure QuickFlu Rapid Flu A+B Test 67

Princeton BioMeditech’s BioSign Flu A+B 67

Response Biomedical’s Influenza A+B Test 68

Sekisui Diagnostics’ OSOM Influenza A & B Test 68

Products in Development 68

Chembio’s DPP Influenza Tests 68

Cepheid’s GeneXpert 69

Lucigen’s Nucleic Acid-Based POC Test 69

Respiratory Syncytial Virus 69

Quidel’s Sofia RSV Fluorescent Immunoassay 70

Quidel’s QuickVue RSV 10 71

Response Biomedical’s RSV Test 71

Other Respiratory Tests 71

Ani Biotech’s Biocard Chlamydia Pneumoniae IgM Test 71

GenBio’s ImmunoFLOW Mycoplasma IgM Test 72

Group A Streptococcus Tests 72

Currently-Available POC Strep A Tests 73

Quidel’s Sofia Strep A Fluorescent Immunoassay 73

H pylori Tests 74

Currently-Available H pylori Tests 74

Exalenz Bioscience’s BreathID System 75

Otsuka America Pharmaceutical’s BreathTek UBT 75

Mononucleosis Tests 76

Currently-Available POC Mono Tests 76

Rotavirus and Adenoviral Enteritis Tests 76

Ani Biotech’s Biocard Tests 76

Meridian Bioscience ImmunoCard STAT! Rotavirus 77

Nicox/Rapid Pathogen Screening’s AdenoPlus 77

Orion Diagnostica’s Diarlex, Rotalex and Adenolex Tests 77

Women’s Heath Diagnostics 77

Ani Biotech’s Biocard Candida and Trichomonas Tests 77

Gryphus Diagnostics’ BVBLUE 77

Quidel’s QuickView Chlamydia Test 78

RunBio Biotech’s Tests 78

Savyon Diagnostics’ SavvyCheck 78

POC TUMOUR MARKER TESTING 79

Fig 13: Global POC Tumour Markers Market, 2007-2017E (US$ million) 79

Prostate Specific Antigen Tests 80

Available Tests 81

Mediwatch’s PSAwatch 81

OPKO Health’s OPKO Diagnostics Platform 82

Occult Blood Testing 82

ACON Laboratories’ Mission FOB Reagent Strips 83

Aerscher Diagnostics’ HemaPrompt 83

Alere’s Tests 83

Beckman Coulter’s Hemoccult Tests 83

Biomerica’s EZ Detect 83

bioMérieux’ bioNexia FOBplus 84

Helena Laboratories’ ColoCare 84

Immunostics’ Hema-Screen 84

Orion Diagnostica’s QuikRead System and Orion Q-flow FOB 84

Princeton BioMeditech’s BioSign iFOBTest 84

Quest Diagnostics’ InSure Quik F I T 85

Quidel’s QuickVue iFOB 85

Other Available FOB Tests 86

Gastric Occult Blood Tests 86

CEA Testing 87

Alpha Fetoprotein Testing 87

Bladder Cancer Testing 87

Alere’s Matritech NMP22 BladderChek Test 88

bioMérieux’ bioNexia BTA 88

Mediwatch’s Bladderwatch BTA Test 88

Novel Products in Development 88

Bioscience Ventures/ Serascience’s POC Myeloma Test 88

Guided Therapeutics’ Non-Invasive Cancer Diagnostic Products 88

LuViva Advanced Cervical Scan 88

Oesophageal and Other Cancer Detection 89

Infopia’s Cancer Diagnosing Sensor 90

POC URINALYSIS TESTING 91

Fig 9: Global POC Urinalysis Market, 2007-2017E (US$ million) 92

Key Urine Analysis Test Strips 92

Product Highlights 92

77 Elektronika’s DocUReader 2 and DocuReader 2 Pro 92

ACON Laboratories’ Mission Products 93

Arkray’s Products 93

PocketChem UA 93

AUTION ELEVEN 93

DiaScreen 50 Urine Chemistry Analyser and DiaScreen Reagent Strips 93

Roche’s Products 93

Urisys 1100 Urine Analyser 93

Chemstrip Criterion II Analyzer 94

Chemstrips/Combur-Test Strips 94

Siemens’ Products 94

Clinitek Status+ 94

Clinitek Status Connect 94

Multistix10 SG Reagent Strips 94

RAPIDComm Data Management and Connectivity Solution 95

Microalbumin Testing 95

Axis-Shield’s Afinion ACR Test 95

Biomerica’s Fortel Microalbumin Screening-OTC Test 96

Orion Diagnostica’s QuikRead U-ALB 96

Quest Diagnostics’ HemoCue Albumin 201 System 96

Sekisui Diagnostics’ OSOM ImmunoDip Urinary Albumin Test 96

Siemens’ Clinitek Microalbumin Strips 96

OTHER PRODUCTS 97

Alere Heart Check System for Heart Failure Monitoring 97

Liver Function Testing 97

Exalenz Bioscience’s BreathID System 97

BreathID Methacetin Breath Test 98

Infopia’s Pioneer POCT Liver Test Sensor 98

Thyroid Tests 98

Jant Pharmacal’s Accutest TSH 98

Screening Devices Canada’s ThyroChek 98

Ani Biotech’s Biocard Coeliac Tests 99

Rapid Pathogen Screening’s InflammaDry 99

Products in Development 100

Akers Biosciences’ BreathPulmo Health Check and Breath Asthma Check 100

POC Breath Asthma Check 100

EMERGING TECHNOLOGIES 101

Applied Nanodetectors’ Sensor Array Platform 101

Ativa Medical’s POC System 101

Bio-AMD’s MPR 102

Biosensia’s RapiPlex 102

Cepheid’s GeneXpert 103

MagnaBioSciences’ MICT On-Site System 104

Molecular Vision 104

MycroLab 105

OPKO Health’s OPKO Diagnostics Platform 106

pes diagnosesysteme’ respons IQ 106

Philips’ Minicare 107

Radisens Diagnostics’ POC Platform 108

T2 Biosystems’ T2Dx System 108

T2Hemostasis Assay 109

Tyrian Diagnostics’ DiagnostIQ 110

MANUFACTURERS 111

COMPANY DIRECTORY 111

SELECTED COMPANY PROFILES 117

Abaxis 117

Piccolo xpress 117

Financial Performance 118

Abaxis Operating Results, 2007-2012 (US$ million) 118

Latest Results 118

Akers Biosciences 119

Recent Key Events 119

Current Products 120

PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays 120

Tri-Cholesterol Check 120

Research and Development 121

BreathPulmo Health Check 121

POC Breath Asthma Check 121

Current Alliances and Distribution Agreements 121

PULSE Health 121

Al Tadawi Medical Equip/PharmaNova Medical Equipment 122

Fisher HealthCare 122

US Government Service Administration Schedule Contract 122

Financial Performance 122

Akers Biosciences Operating Results, 2007-2011 (US$ thousands) 123

Fig 15: Percentage of Akers’ Revenue by Product Type, 2011 123

Alere 124

Recent Key Events 124

POC Cardiology Diagnostic Products 125

Alere Heart Check System 125

Cholestech LDX 125

INRatio2 System 125

Axis-Shield POC Products 125

Afinion POC System 126

NycoCard 126

Coagulation Products 127

POC Oncology Products 127

POC Infectious Disease Tests 127

POC Mergers & Acquisitions 128

Axis-Shield 128

Medical Automation Systems’128

Standard Diagnostics 128

Assets from Unotech Diagnostics 128

Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp 128

Zycare, Medim and Biosyn 129

ACON Laboratories’ Rapid Diagnostics Assets 129

Matria Healthcare 129

BBI Holdings 129

Other Acquisitions 129

Agreements 130

EKF Diagnostics 130

Spartan Bioscience 130

Financial Performance 131

Alere – Operating Results, 2007-2011 (US$ million) 132

Fig 16: Percentage of Alere’s Revenue by Segment, 2011 132

Fig 17: Percentage of Alere’s Revenue by Region, 2011 132

Alere Professional Diagnostics: Operating Results, 2007-2011 (US$ million) 133

Alere Professional Diagnostics: Net Sales & Services Revenue, 2007-2011 (US$ million) 133

Fig 18: Alere Professional Diagnostics: Net Sales & Services Revenue by Product, 2011 133

Latest Results 133

Axis Shield – Financial Performance 134

Fig 19: Axis-Shield Revenue by Business Unit, 2010 135

Fig 20: Axis-Shield Revenue by Region, 2010 135

Axis-Shield – POC Segment Operating Results, 2006-2010 (£ million) 135

Axis-Shield – POC Sales by Product Line, 2006-2010 (£ million) 136

Fig 21: Axis-Shield POC Sales by Product, 2010 136

Fig 22: Axis-Shield Afinion Sales by Region, 2010 136

Arkray 137

Recent Key Events 137

POC Testing Products 137

SpotChem EZ Dry Chemistry Analyser 137

SpotChem D-Concept 138

SpotChem CL SB-1440 Automatic Blood Cell Counter 138

PocketChem BA Blood Ammonia Meters 138

Urinalysis 139

Current Alliances 139

ELITech Group 139

Beckman Coulter (Danaher) 140

POC Products 140

Hemoccult Tests 140

Gastroccult 141

International Technidyne Corporation 142

Products 142

ProTime Coagulation Systems 142

Hemochron Whole Blood Coagulation System 142

Current Alliances 143

Roche 143

Financial Performance 143

International Technidyne Operating Results, 2004-2009 (US$ million) 144

Fig 23: International Technidyne Revenue, 2000-2010 (US$ million) 144

Orion Diagnostica 145

QuikRead 101 System 145

QuikRead go 145

Uricult Dipslide Tests 146

Rotaviral and Adenoviral Enteritis Tests 146

Financial Performance 147

Orion Diagnostica – Operating Results, 2007-2011 (EUR million) 147

Meridian Bioscience 148

TRU FLU and TRU RSV 148

ImmunoCard STAT! HpSA H pylori Test 148

ImmunoCard STAT! Rotavirus 148

ImmunoCard STAT! Strep A 148

ImmunoCard STAT! MONO 148

ImmunoCard STAT! hCG Combo Test 149

Financial Performance 149

Meridian Bioscience – Operating Results, 2008-2012 (US$ million) 149

Meridian Bioscience – Third-Party Sales by Segment, 2008-2012 (US$ million) 149

Meridian Bioscience – Operating Income by Segment, 2008-2012 (US$ million) 149

Fig 24: Meridian Bioscience – Revenue by Segment, 2012 150

Meridian Bioscience – European Diagnostics Sales by Country, 2006-2011 (US$ million) 150

Outlook 150

Quest Diagnostics 151

HemoCue Products 151

Haemoglobin Systems 151

HemoCue Albumin 201 System 152

HemoCue White Blood Cell Analyzer 152

HemoCue WBC DIFF 153

HemoCue Basic Data Management and Connectivity Software 153

Enterix Products 153

InSure Quik F I T Fecal Immunochemical Test 153

Litigation with EKF Diagnostics 154

Financial Performance 154

Quest Diagnostics – Operating Results, 2007-2011 (US$ million) 155

Quest Diagnostics – Sales and Earnings by Category, 2007-2011 (US$ million) 155

Fig 25: Quest Diagnostics – Revenue by Division, 2011 155

Latest Results and Outlook 155

Quidel 157

Recent Key Events 157

Sofia Analyzer and the Sofia Influenza A+B Fluorescent Immunoassay 157

QuickVue Rapid Tests 158

QuickVue Influenza Tests 158

QuickVue Group A Strep Tests 158

QuickVue RSV Tests 158

QuickVue+ Infectious Mononucleosis 159

QuickVue iFOB 159

QuickVue H Pylori gII Test 159

Financial Performance 159

Quidel – Operating Results, 2007-2011 (US$ million) 160

Quidel – Revenue by Product Type, 2008-2011 (US$ million) 160

Fig 26: Quidel – Revenue by Product Type, 2011 160

Fig 27: Quidel – Infectious Disease Revenue, 2005-2011 (US$ million) 161

Quidel – Revenue by Region, 2005-2011 (US$ million) 161

Fig 28: Quidel – Revenue by Region, 2011 161

Latest Results 162

Roche Diagnostics 163

Recent Key Events 163

CoaguChek Systems 164

CoaguChek XS Pro 164

CoaguChek XS Plus 164

CoaguChek XS 164

CoaguChek Link 164

Urinalysis 165

Urisys 1100 Urine Analyser 165

Chemstrip Criterion II Analyzer 165

Chemstrips/Combur-Test Strips 165

Current Alliances and Contracts 165

Panasonic Healthcare 165

Voluntis 166

Financial Performance 166

Roche Diagnostics Operating Results, 2010-2011 (SFr million)166

Fig 29: Roche Diagnostics – Revenue by Product Line, 2011 167

Fig 30: Roche Professional Diagnostics – Revenue by Region, 2011 167

Latest Results 167

Sekisui Diagnostics 168

Point of Care Tests 168

OSOM RSV/Adenovirus Rapid Test 168

OSOM Influenza A & B Test 168

OSOM H pylori 168

OSOM Ultra Strep A 168

OSOM Strep A 169

OSOM Mono 169

OSOM Trichomonas Rapid Test 169

OSOM BVBLUE Test 169

OSOM ImmunoDip Urinary Albumin Test 169

OSOM Pregnancy Tests 169

Siemens Healthcare 170

Products 170

Diabetes Testing – DCA Vantage Analyser 170

Urinlysis Products 171

RAPIDComm Data Management and Connectivity Solution 172

Current Alliances and Supply Contracts 172

Universal Biosensors 172

Premier 173

Roche 173

Financial Performance 173

Latest Results173

Thermo Fisher Scientific 174

Sure-Vue Tests 174

Remel’s Xpect Tests 174

APPENDICES 175

APPENDIX 1 – LIST OF ABBREVIATIONS 175

APPENDIX 2 – REPORT METHODOLOGY 176

Sources 176

Market forecasts 177

Read the full report:

Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017

http://www.reportbuyer.com/pharma_healthcare/diagnostics/physician_based_point_care_diagnostics_products_players_outlook_2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11279592.htm


Source: prweb



comments powered by Disqus